Printer Friendly

Epitomee closes USD 8m in equity fund round led by XT Hi-Tech.

BANKING AND CREDIT NEWS-April 16, 2019-Epitomee closes USD 8m in equity fund round led by XT Hi-Tech

(C)2019 M2 COMMUNICATIONS http://www.m2.com

Epitomee Medical has announced the closing of a USD 8 million equity financing led by Israel-based XT Hi-Tech with participation from investors GCB and Dr. Shimon Eckhouse, the company said.

The funding will enable the company to run its next phase clinical trial equivalent to a Phase 2B drug clinical trial.

Epitomee is a bio-medical company developing treatments for the overweight and obese population, including treatment of glycemic control, weight reduction, and hypertension based on its unique swallowable-device gastric retention platform.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2019 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Banking & Credit News (BCN)
Date:Apr 16, 2019
Words:117
Previous Article:Amount launches account verification platform.
Next Article:Aterian Investment partners with Pace Companies.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters